• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Morbidity and mortality with RSV infection in hospitalized adults. Comparison with seasonal influenza

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Nov 26;S1201-9712(20)32498-X.
doi: 10.1016/j.ijid.2020.11.185. Online ahead of print.
Morbidity and mortality with RSV infection in hospitalized adults. Comparison with seasonal influenza


Alaa Atamna[SUP] 1 [/SUP], Tanya Babich[SUP] 2 [/SUP], Dafi Froimovici[SUP] 3 [/SUP], Dafna Yahav[SUP] 4 [/SUP], Nadav Sorek[SUP] 5 [/SUP], Haim Ben-Zvi[SUP] 5 [/SUP], Leonard Leibovici[SUP] 2 [/SUP], Jihad Bishara[SUP] 4 [/SUP], Tomer Avni[SUP] 6 [/SUP]



Affiliations
Free article

Abstract

Introduction: RSV is considered a major pathogen that causes acute influenza like illness.
Objectives: To compare the clinical outcomes of patients with laboratory-confirmed RSV or influenza infection.
Methods: Adults hospitalized in Beilinson Hospital (October 2017-April 2018) with laboratory-confirmed RSV and influenza.
Primary outcome: composite of RSV/influenza complications: 30-day mortality, pneumonia, mechanical-ventilation, vasopressor-support, ICU admission, myocarditis/encephalitis.
Secondary outcomes: individual components of primary outcome, 90-day mortality, 90-days readmission and length of hospital stay.
Results: 639 patients were included: RSV(113) and influenza(526). The composite outcome was 21.4%(136/633), and was higher in RSV patients [30% (34/113)vs.19% (102/526),p = 0.002]. Pneumonia was more common in RSV patients [21.2% (24/113)vs.9.1% (48/526),p = 0.001]. On multivariable analysis, hypoalbuminemia (OR = 3.3, 95%CI 2.1-5.3, p < 0.001), reduced room-air saturation (OR = 1.1, 95%CI 1.02-1.1; p = 0.001) and infection with RSV (OR = 1.67, 95%CI 1.01-2.76, p = 0.046) were predictors for complications.
Conclusion: RSV infection in hospitalized adults resulted in serious respiratory illness with complications that are comparable with those caused by influenza.

Keywords: RSV; influenza; mortality; outcomes; respiratory syncytial virus.
 
Back
Top Bottom